Risk to Benefit Ratio: when is a drug too risky to stay on the market?

Pundits have said it takes at least 100 deaths for the FDA to act regarding pulling a prescription drug from the marketplace. The playing field is far from level for risky medications versus the risks of supplements including herbs. It is of little comfort to consumers that the FDA has no written guidelines for deciding… Continue reading Risk to Benefit Ratio: when is a drug too risky to stay on the market?

Supplements In The Senate—Again!

The Senate Special Committee on Aging is chaired by Senator Herb Kohl (D-WI). The Committee may be about to take some potshots at supplements during a hearing scheduled for tomorrow, May 26. Everyone involved is being very hush-hush on what they’ll be discussing, but we have learned of several items on the agenda.